Partner Dan Shores will present on "The IP Landscape in the mRNA Space: Winning with Knowledge, Strategy & Innovation" at the 3rd Annual mRNA-Based Therapeutics Summit taking place July 26-28, 2023, in Boston, Massachusetts. Dan's session will be held on Thursday, July 27 during the Clinical Development track. Dan will also participate in a panel session, "Optimizing Targeted Delivery & Cell Specificity," during the Pre-Conference Focus Day on Wednesday, July 26.
Dan's session on July 27 will provide an overview of the IP landscape in the mRNA space; share key strategies to operate, collaborate, and win; and evaluate innovation approaches and trends. The panel he's participating in on July 26 will aim to answer questions such as what does targeted delivery success look like?; what will make an mRNA therapeutic powerful?; and how can we target the most challenging organs?
The mRNA-Based Therapeutics Summit is returning for its 3rd year this July, showcasing exclusive new data from the movers and shakers in the mRNA industry. 500+ industry pioneers from the likes of the FDA, Pfizer, Moderna, BioNTech, Sanofi and many more are joining the world’s only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines.
To learn more about the event, and to register, please visit the event website.
